RIVINTRA-2.5
MRP: 1,500
Packaging: 10X10
Pack Type: tablet
Composition:
Rivaroxaban 2.5mg
Indication:
In Treatment & Prevention of Blood Clots
Description:
Each tablet contains Rivaroxaban 2.5mg, an oral anticoagulant that directly inhibits Factor Xa, a key enzyme in the blood clotting process. Rivaroxaban belongs to a class of drugs known as DOACs (Direct Oral Anticoagulants) and is indicated for the prevention of atherothrombotic events in patients with coronary artery disease (CAD) or peripheral artery disease (PAD), and may also be used alongside low-dose aspirin in certain cardiovascular risk management protocols. Its low-dose formulation (2.5mg) is particularly designed for long-term secondary prevention with a favorable safety profile.
Tags:
- Direct Factor Xa inhibitor with predictable anticoagulant effect
- Reduces risk of stroke and systemic embolism
- Suitable for long-term cardiovascular risk management
- No need for routine blood monitoring
- Convenient once- or twice-daily dosing
Usage Information
Dosage
Typical dose: 2.5mg twice daily (every 12 hours), with or without food Often prescribed in combination with low-dose aspirin (75–100 mg once daily) Take at the same times daily for best results Do not skip or double doses Always follow the prescribed regimen. Do not discontinue without medical consultation.
Side Effects
Common side effects: Bleeding (nosebleeds, gum bleeding, bruising) Headache or dizziness Nausea Serious side effects (seek immediate help): Unusual or prolonged bleeding Blood in urine or stool Intracranial bleeding (rare) Allergic reactions (rash, swelling, breathing issues)
Contraindications
Active pathological bleeding Severe renal impairment (e.g., creatinine clearance <15 mL/min) Hepatic disease with associated coagulopathy Hypersensitivity to Rivaroxaban or excipients Concomitant use with other anticoagulants (unless advised) Pregnancy and breastfeeding (unless advised by a physician)